INTS (Intensity Therapeutics) Wutah pendapatan kuartal marang kuartal

Tandha merek Intensity Tx (INTS)

Intensity Therapeutics is developing cancer immunotherapy via the DITA platform, where patent potential may offset testing costs. Environmental regulations require the company to implement energy-saving measures, while AI modules automate data collection. The GURU.Markets terminal provides the quarterly revenue change history, where 0.00 reflects the latest metric value, linking market capitalization to actual sales.

intensitytherapeutics.com (INTS) - Owah-owahan pendapatan dibandhingake kuartal kepungkur saka 21.02.2024 nganti 20.11.2026

Rincian analitis perusahaan Intensity Tx (INTS)

Analisis dhasar perusahaan:INTS - Intensity Tx
Produk sing diprodhuksi Intensity Therapeutics Inc

Intensity Therapeutics is optimizing costs by delegating production to international contract manufacturing organizations to ensure uninterrupted drug supplies. By analyzing quarterly revenue growth dynamics, an investor assesses the pace of income expansion over three months, which allows for the rapid identification of an operational downturn or the confirmation of a recovery growth stage, thereby determining the fundamental viability and investment attractiveness of the business.

Perusahaan pesaing

IBRX - Wutah pendapatan kuartal marang kuartal|IMCR (immunocore.com) - Wutah dodolan kuartal marang kuartal|Janux Corp (JANX) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Arcus Bio (RCUS)|Wutah dodolan triwulanan ZYME|TNGX - Owah-owahan pendapatan dibandhingake kuartal kepungkur|Wutah dodolan triwulanan IOVA (Iovance)|Owah-owahan dodolan kuartal marang kuartal IMTX|Wutah pendapatan triwulanan XNCR (Xencor)|Tambahing pendapatan triwulanan CMPX|replimune.com - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Lyell Pharma|Innate Pharma S.A. (IPHA) - Wutah pendapatan kuartal marang kuartal|Pyxis Oncology Inc. - Tambahing pendapatan triwulanan|CGEN (Compugen Limited) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan IO Biotech Inc|Wutah pendapatan kuartal marang kuartal Sutro Biopharma (STRO)|INKT: Dinamika pendapatan kuartal marang kuartal|Werewolf Therapeutics, Inc. - Wutah dodolan triwulanan|Immix (IMMX) - Tingkat wutah pendapatan sajrone kuartal|ALX Oncology Holdings Inc. - Wutah pendapatan triwulanan|CUE - Wutah pendapatan triwulanan|PDSB: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan Liminatus Pharma (LIMN)|Wutah pendapatan triwulanan LVTX|Owah-owahan dodolan kuartal marang kuartal NXTC|Leap Therapeutics, Inc. - Wutah dodolan triwulanan|Sensei Bio (SNSE) - Tingkat wutah pendapatan sajrone kuartal|TOVX: Wutah dodolan triwulanan|Gritstone bio - Owah-owahan dodolan kuartal marang kuartal|Kineta Bio (KA) - Wutah pendapatan kuartal marang kuartal|NexImmune Inc (NEXI) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Turnstone Biologics Corp.|Wutah dodolan kuartal marang kuartal VCNX (Vaccinex, Inc.)|Wutah dodolan triwulanan HARP (Harpoon Tx)